News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
632,629 Results
Type
Article (58286)
Company Profile (196)
Press Release (574139)
Multimedia
Podcasts (87)
Webinars (24)
Section
Business (159891)
Career Advice (1486)
Deals (27513)
Drug Delivery (93)
Drug Development (83826)
Employer Resources (107)
FDA (14312)
Job Trends (12498)
News (286556)
Policy (24135)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Genetown Standard (4)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (2843)
Academic (1)
Accelerated approval (52)
ADA (40)
Adcomms (38)
Allergies (195)
Alliances (44986)
ALS (236)
Alzheimer's disease (1926)
Antibody-drug conjugate (ADC) (539)
Approvals (14747)
Artificial intelligence (737)
ASCO (344)
Autoimmune disease (364)
Automation (57)
Bankruptcy (220)
Best Places to Work (10108)
BIO (67)
BIOSECURE Act (18)
Biosimilars (184)
Biotechnology (140)
Bladder cancer (205)
Brain cancer (81)
Breast cancer (819)
Cancer (6399)
Cardiovascular disease (508)
Career advice (1274)
Career pathing (38)
CAR-T (360)
CDC (34)
Celiac Disease (3)
Cell therapy (983)
Cervical cancer (57)
Clinical research (73518)
Collaboration (2237)
Commercialization (1)
Company closure (5)
Compensation (1161)
Complete response letters (84)
COVID-19 (2666)
CRISPR (116)
C-suite (1159)
Cystic fibrosis (158)
Data (8780)
Decentralized trials (3)
Denatured (31)
Depression (182)
Dermatology (91)
Diabetes (630)
Diagnostics (6590)
Digital health (58)
Diversity (13)
Diversity, equity & inclusion (27)
Drug discovery (372)
Drug pricing (109)
Drug shortages (18)
Duchenne muscular dystrophy (295)
Earnings (62790)
Editorial (54)
Employer branding (14)
Employer resources (100)
Events (95653)
Executive appointments (1058)
FDA (18219)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (1848)
Gene editing (243)
Generative AI (61)
Gene therapy (744)
GLP-1 (963)
Government (3423)
Grass and pollen (7)
Guidances (394)
Healthcare (17019)
Hematology (192)
HIV (78)
Huntington's disease (63)
IgA nephropathy (109)
Immunology and inflammation (287)
Immuno-oncology (109)
Indications (217)
Infectious disease (3008)
Inflammatory bowel disease (239)
Inflation Reduction Act (8)
Influenza (138)
Intellectual property (304)
Interviews (287)
IPO (13976)
IRA (35)
Job creations (2685)
Job search strategy (1071)
JPM (40)
Kidney cancer (22)
Labor market (85)
Layoffs (469)
Leadership (28)
Legal (4206)
Liver cancer (101)
Longevity (33)
Lung cancer (837)
Lymphoma (468)
Machine learning (61)
Management (37)
Manufacturing (946)
Marketing (4)
MASH (211)
Medical affairs (1)
Medical device (11626)
Medtech (11771)
Mergers & acquisitions (14812)
Metabolic disorders (1480)
mRNA (219)
Multiple sclerosis (200)
NASH (15)
Neurodegenerative disease (488)
Neuropsychiatric disorders (107)
Neuroscience (3592)
Neurotech (1)
NextGen: Class of 2026 (5413)
Non-profit (4079)
Now hiring (67)
Obesity (611)
Opinion (283)
Ovarian cancer (243)
Pain (264)
Pancreatic cancer (361)
Parkinson's disease (414)
Partnered (32)
Patents (584)
Patient recruitment (798)
Peanut (65)
People (50252)
Pharmaceutical (40)
Pharmacy benefit managers (16)
Phase 1 (23421)
Phase 2 (32446)
Phase 3 (23658)
Pipeline (9699)
Policy (250)
Postmarket research (2643)
Preclinical (9798)
Press Release (67)
Prostate cancer (335)
Psychedelics (57)
Radiopharmaceuticals (351)
Rare diseases (1176)
Real estate (4975)
Recruiting (46)
Regulatory (22055)
Reports (36)
Research institute (2697)
Resumes & cover letters (216)
Rett syndrome (46)
RNA editing (23)
RSV (74)
Schizophrenia (180)
Series A (322)
Series B (236)
Service/supplier (11)
Sickle cell disease (119)
Special edition (24)
Spinal muscular atrophy (178)
Sponsored (43)
Startups (3246)
State (2)
Stomach cancer (17)
Supply chain (96)
Tariffs (41)
The Weekly (56)
Vaccines (1049)
Venture capital (96)
Weight loss (359)
Women's health (132)
Worklife (13)
Date
Today (104)
Last 7 days (477)
Last 30 days (2281)
Last 365 days (28519)
2026 (15217)
2025 (28391)
2024 (32755)
2023 (37306)
2022 (48151)
2021 (51735)
2020 (48720)
2019 (39992)
2018 (30321)
2017 (29144)
2016 (28247)
2015 (33339)
2014 (25829)
2013 (21945)
2012 (22221)
2011 (22781)
2010 (21552)
Location
Africa (696)
Alabama (90)
Alaska (5)
Arizona (271)
Arkansas (11)
Asia (38687)
Australia (7275)
California (13124)
Canada (3492)
China (1510)
Colorado (553)
Connecticut (597)
Delaware (385)
Europe (88861)
Florida (1942)
Georgia (428)
Hawaii (2)
Idaho (52)
Illinois (967)
India (89)
Indiana (569)
Iowa (22)
Japan (582)
Kansas (124)
Kentucky (50)
Louisiana (54)
Maine (79)
Maryland (1488)
Massachusetts (9438)
Michigan (342)
Minnesota (608)
Mississippi (7)
Missouri (132)
Montana (33)
Nebraska (23)
Nevada (138)
New Hampshire (80)
New Jersey (3385)
New Mexico (32)
New York (3518)
North Carolina (1701)
North Dakota (9)
Northern California (6671)
Ohio (385)
Oklahoma (24)
Oregon (39)
Pennsylvania (2510)
Puerto Rico (22)
Rhode Island (42)
South America (854)
South Carolina (70)
South Dakota (1)
Southern California (5191)
Tennessee (208)
Texas (2228)
United States (45926)
Utah (371)
Vermont (2)
Virginia (319)
Washington D.C. (67)
Washington State (1096)
West Virginia (3)
Wisconsin (127)
Wyoming (2)
632,629 Results for "lotus clinical research llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Palvella Therapeutics Announces First Patients Dosed in Phase 2 LOTU Trial of Fast Track-Designated QTORIN™ Rapamycin for Clinically Significant Angiokeratomas
May 4, 2026
·
9 min read
Press Releases
START Research Expands Clinical Leadership with Appointment of Dr. Neel Belani as Clinical Investigator at START New Jersey
Strengthening clinical research capabilities in one of the nation’s most densely populated and high-opportunity oncology markets
April 30, 2026
·
1 min read
Press Releases
Paradigm Clinical Research Opens Psychedelic Research Suite in Redding, California
New specialized treatment site expands Paradigm’s capabilities for psychiatric clinical trials and studies evaluating investigational psychedelic-assisted therapies
June 18, 2026
·
1 min read
Press Releases
LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC
March 16, 2026
·
5 min read
Press Releases
Headlands Research Expands California Presence with Acquisition of Clinical Trials Research
June 30, 2026
·
2 min read
Press Releases
AMR Clinical Acquires ClinOhio Research Services
June 29, 2026
·
2 min read
Press Releases
Paradigm Clinical Research Appoints Greg Licholai, MD, to Board of Directors
Physician-executive with 30+ years across clinical practice, biotech, and digital health joins board to advance Paradigm’s mission and growth
June 10, 2026
·
1 min read
Press Releases
Theriva™ Biologics Announces Results from VCN-01 Phase 1 Clinical Trial in Head and Neck Cancer Published in Clinical Cancer Research
June 11, 2026
·
8 min read
Press Releases
Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa
May 6, 2026
·
10 min read
Press Releases
Alliance Clinical Network and Atlas Clinical Research Announce Strategic Merger
June 2, 2026
·
3 min read
1 of 63,263
Next
